SCHEMBL7160902

SCHEMBL7160902

CCN(CC)CCN(CCN(CC)CC)c1ccc(-c2nc3ccncc3n2C(C)=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
MAPT P10636 4/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HSD17B10 Q99714 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
LMNA P02545 2/20 0.49
TP53 P04637 2/20 0.49
GSK3B P49841 1/20 0.35
DRD2 P14416 6/20 0.35
DRD3 P35462 6/20 0.35
TSHR P16473 2/20 0.34
MAOA P21397 1/20 0.34
KCNH2 Q12809 2/20 0.34
HTT P42858 2/20 0.34
AOC3 Q16853 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7156031 0.91 MAPT (0.58) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL8520036 0.88 KDM4E (0.48) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL7153769 0.87 HDAC1 (0.39) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL8520141 0.86 NPC1 (0.67) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL7154096 0.85 NPC1 (0.65) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL7160138 0.85 ALDH1A1 (0.46) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL7554486 0.84 KDM4E (0.51) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL7155292 0.81 MYC (0.39) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL7660693 0.81 HSD17B10 (0.40) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL7160069 0.81 KDM4E (0.37) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534521-B2 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection MILLENNIUM PHARMACEUTICALS, INC. 2003-03-18 US disclosed
US-6348487-B1 ANTIINFLAMMATORY AGENTS, ATHEROSCLEROSIS, RESTINOSIS AND IMMUNE DISORDERS MILLENNIUM PHARMACEUTICALS, INC. 2002-02-19 US disclosed
US-6184235-B1 MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) ANTAGONIST FOR TREATMENT OF INFLAMMATORY DISEASES, ATHEROSCLEROSIS, RESTENOSIS, AUTOIMMUNE DISEASES, ORGAN TRANSPLANT REJECTION IN MAMMALS WARNER-LAMBERT COMPANY 2001-02-06 US disclosed